Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study
Background: About 37 million people are living with human-immunodeficiency-virus (HIV) worldwide, with 2.6 million co-infected with the hepatitis B virus (HBV). HBV infection causes 650 000 deaths annually worldwide. Botswana has a high prevalence of HIV and a growing population of patients on highl...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2017-07-01
|
Series: | South African Family Practice |
Subjects: | |
Online Access: | https://safpj.co.za/index.php/safpj/article/view/4716 |
_version_ | 1818357298719883264 |
---|---|
author | Azhani Mandiwana Stephane Tshitenge |
author_facet | Azhani Mandiwana Stephane Tshitenge |
author_sort | Azhani Mandiwana |
collection | DOAJ |
description | Background: About 37 million people are living with human-immunodeficiency-virus (HIV) worldwide, with 2.6 million co-infected with the hepatitis B virus (HBV). HBV infection causes 650 000 deaths annually worldwide. Botswana has a high prevalence of HIV and a growing population of patients on highly active antiretroviral therapy (HAART). This study aimed to determine the prevalence of HIV–HBV co-infection amongst HAART eligible adult patients in some rural settings in Botswana.
Methods: A cross-sectional study was conducted amongst HAART eligible adult patients at 15 HAART clinics in the Mahalapye, Ngami and Serowe Health Districts of Botswana, from August to October 2015. A total of 132 were recruited; of these 118 consented and were tested for HBsAg reactivity using Elisa.
Results: Six (5.1%, 6/118) patients from the three rural health districts were HIV–HBV co-infected, with three in the 20–29 age group. The association between sex and HIV–HBV co-infection status was not statistically significant; p = 1.00.
Conclusion: The finding of 5.1% HIV–HBV co-infection prevalence in some rural settings of Botswana was similar to results from one study conducted in a Botswana urban centre, while another previous similar study reported prevalence as being twice as high. This finding may call for prioritisation of pre-HAART HBV screening and early HAART initiation for all HIV-infected patients.
(Full text of the research articles are available online at www.medpharm.tandfonline.com/ojfp)
S Afr Fam Pract 2017; DOI: 10.1080/20786190.2016.1272230 |
first_indexed | 2024-12-13T20:10:53Z |
format | Article |
id | doaj.art-40a5b0ed5dce4dd08fd3685cefcb4409 |
institution | Directory Open Access Journal |
issn | 2078-6190 2078-6204 |
language | English |
last_indexed | 2024-12-13T20:10:53Z |
publishDate | 2017-07-01 |
publisher | AOSIS |
record_format | Article |
series | South African Family Practice |
spelling | doaj.art-40a5b0ed5dce4dd08fd3685cefcb44092022-12-21T23:32:55ZengAOSISSouth African Family Practice2078-61902078-62042017-07-0159310.4102/safp.v59i3.47163758Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional studyAzhani Mandiwana0Stephane Tshitenge1Botswana Defence ForceUniversity of BotswanaBackground: About 37 million people are living with human-immunodeficiency-virus (HIV) worldwide, with 2.6 million co-infected with the hepatitis B virus (HBV). HBV infection causes 650 000 deaths annually worldwide. Botswana has a high prevalence of HIV and a growing population of patients on highly active antiretroviral therapy (HAART). This study aimed to determine the prevalence of HIV–HBV co-infection amongst HAART eligible adult patients in some rural settings in Botswana. Methods: A cross-sectional study was conducted amongst HAART eligible adult patients at 15 HAART clinics in the Mahalapye, Ngami and Serowe Health Districts of Botswana, from August to October 2015. A total of 132 were recruited; of these 118 consented and were tested for HBsAg reactivity using Elisa. Results: Six (5.1%, 6/118) patients from the three rural health districts were HIV–HBV co-infected, with three in the 20–29 age group. The association between sex and HIV–HBV co-infection status was not statistically significant; p = 1.00. Conclusion: The finding of 5.1% HIV–HBV co-infection prevalence in some rural settings of Botswana was similar to results from one study conducted in a Botswana urban centre, while another previous similar study reported prevalence as being twice as high. This finding may call for prioritisation of pre-HAART HBV screening and early HAART initiation for all HIV-infected patients. (Full text of the research articles are available online at www.medpharm.tandfonline.com/ojfp) S Afr Fam Pract 2017; DOI: 10.1080/20786190.2016.1272230https://safpj.co.za/index.php/safpj/article/view/4716botswanahbsag screeninghiv–hbv co-infection prevalence |
spellingShingle | Azhani Mandiwana Stephane Tshitenge Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study South African Family Practice botswana hbsag screening hiv–hbv co-infection prevalence |
title | Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study |
title_full | Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study |
title_fullStr | Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study |
title_full_unstemmed | Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study |
title_short | Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study |
title_sort | prevalence of human immunodeficiency virus hepatitis b virus co infection amongst adult patients in mahalapye ngami serowe botswana a descriptive cross sectional study |
topic | botswana hbsag screening hiv–hbv co-infection prevalence |
url | https://safpj.co.za/index.php/safpj/article/view/4716 |
work_keys_str_mv | AT azhanimandiwana prevalenceofhumanimmunodeficiencyvirushepatitisbviruscoinfectionamongstadultpatientsinmahalapyengamiserowebotswanaadescriptivecrosssectionalstudy AT stephanetshitenge prevalenceofhumanimmunodeficiencyvirushepatitisbviruscoinfectionamongstadultpatientsinmahalapyengamiserowebotswanaadescriptivecrosssectionalstudy |